Centrose is a biopharmaceutical company committed to the discovery and development of safe and effective FDA approved therapies for pancreatic and other hard to treat cancers. We have identified targeted therapeutics called EDCs that stop tumor growth while reducing inflammation and activating the body's defense mechanisms; all leading to safe and effective treatments for cancer patients.
Specifically, Centrose discovered that cardiotonic steroids (once thought to only block ion trafficking) are actually extremely potent signal transducers and when targeted, kill cancer. Using EDC technology, these steroids can be directed to specific types of diseases. In model studies, antibody targeted cardiotonic steroids have now been shown to cure cancer at safe doses while never blocking ion traffic in and out of cells.